| Name |
Relfydess 100 jedinica/ml otopina za injekciju |
| Marketing Authorisation Number |
HR-H-294064563 |
| Active Substance |
neurotoksin Clostridium botulinum tip A (150 kDa), ne sadrži proteinske komplekse |
| Composition |
jedna bočica sadrži 150 jedinica botulinskog toksina tipa A, bez proteinskih kompleksa u 1,5 ml otopine |
| Pharmaceutical Form |
otopina za injekciju |
| Manufacturer |
Q-Med AB, Uppsala, Švedska |
| Marketing Authorisation Holder |
Ipsen Pharma, 70 Rue Balard, Pariz, Francuska |
| Marketing Authorisation Date |
09.06.2026 |
| MA Period of Validity |
09.06.2031 |
| Classification Number |
UP/I-530-09/25-01/376 |
| Registration Number |
381-12-01/286-26-13 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product subject to restricted medical prescription
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
M03AX01 |
| Marketing status |
Never marketed |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|